Julianne Averill
Directeur Financier/CFO chez Oxeia Biopharmaceuticals, Inc.
Profil
Julianne Averill is currently the Chief Financial Officer at Oxeia Biopharmaceuticals, Inc. She previously worked as the Director-Financial Reporting at Starwood Waypoint Homes and as the Vice President-Finance at BlackThorn Therapeutics, Inc. She also served as the Chief Financial & Accounting Officer at Armata Pharmaceuticals, Inc. Ms. Averill completed her undergraduate and graduate degrees at The California State University.
Postes actifs de Julianne Averill
| Sociétés | Poste | Début |
|---|---|---|
Oxeia Biopharmaceuticals, Inc.
 Oxeia Biopharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Oxeia Biopharmaceuticals, Inc. is a clinical-stage biotech company, which develops new, innovative therapies for conditions that are defined by deficits in neurocognition from injury, degeneration and aging. Its two indications are for (i) mild traumatic brain injury (?mTB?) known as concussion, and (ii) the cognitive decline, lethargy and ?brain-fog? associated with Covid-19 infection, known as Covid Longhauler syndrome (?Long Covid?). The company was founded in 2014 by Vishal Bansal, Amit Dilip Munshi & Kartik Kiran Shah and is headquartered in Boston, MA. | Directeur Financier/CFO | 01/12/2021 |
Anciens postes connus de Julianne Averill
| Sociétés | Poste | Fin |
|---|---|---|
BlackThorn Therapeutics, Inc.
 BlackThorn Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Blackthorn Therapeutics, Inc. manufactures and markets medicines for neuro developmental disorders. The company is headquartered in San Francisco, CA. | Corporate Officer/Principal | 01/07/2020 |
| ARMATA PHARMACEUTICALS, INC. | Directeur Financier/CFO | 15/09/2023 |
| STARWOOD WAYPOINT HOMES | Corporate Officer/Principal | - |
Formation de Julianne Averill
| The California State University | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| ARMATA PHARMACEUTICALS, INC. | Health Technology |
| Entreprise privées | 3 |
|---|---|
Oxeia Biopharmaceuticals, Inc.
Oxeia Biopharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Oxeia Biopharmaceuticals, Inc. is a clinical-stage biotech company, which develops new, innovative therapies for conditions that are defined by deficits in neurocognition from injury, degeneration and aging. Its two indications are for (i) mild traumatic brain injury (?mTB?) known as concussion, and (ii) the cognitive decline, lethargy and ?brain-fog? associated with Covid-19 infection, known as Covid Longhauler syndrome (?Long Covid?). The company was founded in 2014 by Vishal Bansal, Amit Dilip Munshi & Kartik Kiran Shah and is headquartered in Boston, MA. | Health Technology |
BlackThorn Therapeutics, Inc.
BlackThorn Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Blackthorn Therapeutics, Inc. manufactures and markets medicines for neuro developmental disorders. The company is headquartered in San Francisco, CA. | Health Technology |
Starwood Waypoint Homes
 Starwood Waypoint Homes Real Estate Investment TrustsFinance Starwood Waypoint Homes is a real estate investment trust, which engages in the acquisition, renovation, lease, maintenance, and management of single-family rental homes. The company was founded in March 2012 and is headquartered in Scottsdale, AZ. | Finance |
